Notifications
Back
mobile background
NeuFlow, the solution trusted by patients and chosen by professionals.

Discover the value of MediImage’s unrivaled technology through real-world experiences and success stories from leading medical institutions in Korea and around the world that have chosen NeuFlow.

0

The number of

patients analyzed using NeuFlow

Partner Hospitals and Client Testimonials

Real experiences from leading medical institutions and specialists in Korea and abroad. See firsthand how NeuFlow is transforming clinical practice.

0
Units Installed
0
Patient Analysis
0
User Satisfaction
Voices from Frontline Medical Professionals
“
"Ah... This feels like viewing a PET scan of an MRA. The color visualization allows for immediate recognition and provides clear confidence."
Neurology Specialist
President of the Nation’s Only Specialized Neurology Hospital in Korea
“
"This is the product that will lift the blindfolds of neurologists around the world. You can now see cerebral blood vessels in both color and numbers."
Neurology Specialist
Director of a Neurology Specialty Hospital (President of the Korean Neurological Association)
“
"Patients are coming to the hospital on their own after hearing that we use NeuFlow for interpretation."
Neurology Specialist
Director of a Private Neurology Clinic and Former University Professor

Case Study :
Changes in Patient Satisfaction After Adopting NeuFlow at a Neurology Specialty Hospital

After introducing NeuFlow , the hospital saw a significant increase in both patient satisfaction and return visit rates. In particular, regular check-up patients showed a 15% improvement in engagement with their health management, thanks to the detailed cerebral blood vessel health reports.

100% 75% 50% 25% 0%
Patient Satisfaction
Patient Referrals
Patient Return Rate
Result Comprehension
94%
22%
70%
68%
Key Metrics Comparison Before and After NeuFlow Implementation
  • Patient Satisfaction: Before Implementation 72% → After Implementation 94%
  • Referral Growth Rate: A 22% Increase in Monthly Average
  • Patient Return Rate: 35% Improvement
  • Patient Understanding of Test Results: 68% Improvement
mobile background
Voices from Frontline Medical Professionals
“
"Ah... This feels like viewing a PET scan of an MRA. The color visualization allows for immediate recognition and provides clear confidence."
Neurology Specialist
President of the Nation’s Only Specialized Neurology Hospital in Korea
“
"This is the product that will lift the blindfolds of neurologists around the world. You can now see cerebral blood vessels in both color and numbers."
Neurology Specialist
Director of a Neurology Specialty Hospital (President of the Korean Neurological Association)
“
"Patients are coming to the hospital on their own after hearing that we use NeuFlow for interpretation."
Neurology Specialist
Director of a Private Neurology Clinic and Former University Professor

Case Study: Changes in Patient Satisfaction After Adopting NeuFlow at a Neurology Specialty Hospital

After introducing NeuFlow, the hospital saw a significant increase in both patient satisfaction and return visit rates. In particular, regular check-up patients showed a 15% improvement in engagement with their health management, thanks to the detailed cerebral blood vessel health reports.

100% 75% 50% 25% 0%
Patient
Satisfaction
Patient Referrals
Patient
Return Rate
Result
Comprehension
72%
94%
0%
22%
35%
70%
30%
68%
Key Metrics Comparison Before and After NeuFlow Implementation
  • Patient Satisfaction: Before Implementation 72% → After Implementation 94%
  • Referral Growth Rate: A 22% Increase in Monthly Average
  • Patient Return Rate: 35% Improvement
  • Patient Understanding of Test Results: 68% Improvement
NEWS
MediImage's Innovation,
Transforming the World with Breakthroughs
Stay Updated on MediImage’s Latest Advances in Cerebrovascular Diagnosis.
Join us as we share our journey of innovative technology and global expansion.
Post thumbnail
The Risk of Cerebral Aneurysm
A Headache That Feels Like Being Hit by a Hammer or Struck by Lightning…What Could It Be?The key to treating all emergency conditions lies in securing the "golden time."However, there is one condition where the golden time becomes meaningless once it ruptures.That condition is a "cerebral aneurysm.A cerebral aneurysm is a condition where a specific area of a cerebral artery, which supplies blood to the brain, swells like a balloon or a pouch.If left untreated, a ruptured cerebral aneurysm can lead to a subarachnoid hemorrhage (brain hemorrhage).Experts advise that cerebral aneurysms can be effectively prevented with early diagnosis and appropriate treatment. According to the medical community on the 22nd, cerebral aneurysms are difficult to detect as they typically show no symptoms until they rupture.However, in rare cases, symptoms such as strabismus, double vision, or ptosis (drooping eyelids) may occur due to cranial nerve compression.When a cerebral aneurysm ruptures, blood leaks into the subarachnoid space in the brain, causing severe headaches described as "being hit by a hammer" or "lightning striking the head," often accompanied by vomiting.Depending on the extent of the bleeding, symptoms such as paralysis or speech impairments may occur, and in severe cases, it can lead to death.Dr. Seo Dae-cheol, Clinical Director of the Department of Neurointerventional Medicine at Gangnam Bedro Hospital, stated, “If you experience a headache accompanied by drooping eyelids, it could be a warning sign of a cerebral aneurysm rupture. Immediate consultation with a specialist and prompt treatment are essential.” The exact cause of cerebral aneurysm development remains unclear.However, the most commonly identified risk factors include hypertension, atherosclerosis, diabetes, and smoking.Women are 1.6 times more likely to develop cerebral aneurysms than men. Individuals with hypertension have a 1.5 times higher risk, those with heart disease have a 2 times higher risk, and those with a family history of stroke are 1.8 times more likely to develop the condition.In terms of age, the incidence rate is highest among individuals in their 40s to 60s, with cases beginning to appear from the 30s.To determine the presence of a cerebral aneurysm, an initial examination is conducted using computed tomography (CT) angiography.If suspicious findings are detected, further tests such as magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA) are performed to assess the detailed location, shape, and size of the aneurysm.
New post
About MEDIIMG

A Leading Enterprise

in Overcoming Cerebrovascular Diseases


MEDIIMAGE, a company specializing in hemodynamics and AI, is dedicated to advancing technology and research to overcome cerebrovascular diseases such as brain aneurysms. 

About MEDIIMG

A Leading Enterprise

in Overcoming Cerebrovascular Diseases


MEDIIMAGE, a company specializing in hemodynamics and AI,

is dedicated to advancing technology and research

to overcome cerebrovascular diseases such as brain aneurysms. 

MISSION

Lighting the way with our companion

We strive for innovation in cerebrovascular health with new biomarkers.

FUTURE

We will light the way

with our companion

We design a healthier future with vascular biomarkers. MediImage Co., Ltd. is ushering in a new era of cerebrovascular disease diagnosis and prevention through innovative methods of quantifying cerebrovascular information.

mobile background
MISSION
Lighting the way with our companion

We strive for innovation in cerebrovascular health with new biomarkers. 

FUTURE
We will light the way with our companions

We design a healthier future with vascular biomarkers.
MediImage Co., Ltd. is ushering in a new era of cerebrovascular disease diagnosis

and prevention through innovative methods of quantifying cerebrovascular information.

Our History
Our History
2024

11｜FloCal Medical Device Manufacturing Certification - Ministry of Food and Drug Safety (MFDS)  

10｜FDA 510K Approved 

Selected for the TIPS Follow-up Program - Ministry of SMEs and Startups (MSS)  

06｜Selected for the TIPS Program - Ministry of SMEs and Startups (MSS)

Healthcare Industry Patent Strategy and Regulatory Consulting Support Program - Korea Health Industry Development Institute (KHIDI) 

2023

12｜Secured Seed Funding from Bluepoint Partners 

10｜Venture Business Certification  

08｜Approved for New Medical Technology Application Eligibility - National Evidence-based Healthcare Collaborating Agency (NECA) 

Bio & Medical Company Competency Enhancement Program - Korea Advanced Institute of Science and Technology (KAIST)  

06｜Overseas Certification Acquisition Support Program (FDA) - Ministry of SMEs and Startups (MSS)   

01｜NeuFlow  Medical Device Manufacturing Certification - Ministry of Food and Drug Safety (MFDS)  

2022

10｜Certified for Good Manufacturing Practice (GMP) for Medical Devices - Korea Conformity Laboratories (KCL) 

09｜User Compatibility Evaluation Completed - Gachon University Medical Device Convergence Center 

2021

11｜R&D Funding Guarantee - Korea Technology Finance Corporation (KOTEC) 

Startup Growth Technology Development Program (Didimdol) - Ministry of SMEs and Startups (MSS)  

07｜Certified R&D Department - Ministry of Science and ICT 

2018

01｜Establishment of MediImg 

mobile background
mobile background
2024

11｜FloCal Medical Device Manufacturing Certification - Ministry of Food and Drug Safety (MFDS)

10｜FDA 510K Approved

Selected for the TIPS Follow-up Program - Ministry of SMEs and Startups (MSS)

06｜Selected for the TIPS Program

Healthcare Industry Patent Strategy and Regulatory Consulting Support Program - Korea Health Industry Development Institute (KHIDI)

mobile background
2023

12｜Secured Seed Funding from Bluepoint Partners

10｜Venture Business Certification

08｜Approved for New Medical Technology Application Eligibility - National Evidence-based Healthcare Collaborating Agency (NECA)

Bio & Medical Company Competency Enhancement Program - Korea Advanced Institute of Science and Technology (KAIST)  

06｜Overseas Certification Acquisition Support Program (FDA) - Ministry of SMEs and Startups (MSS)  

01｜NeuFlow  Medical Device Manufacturing Certification - Ministry of Food and Drug Safety (MFDS)

mobile background
2022

10｜Certified for Good Manufacturing Practice (GMP) for Medical Devices - Korea Conformity Laboratories (KCL)   

09｜User Compatibility Evaluation Completed - Gachon University Medical Device Convergence Center  

mobile background
2021

11｜R&D Funding Guarantee - Korea Technology Finance Corporation (KOTEC)

Startup Growth Technology Development Program (Didimdol) - Ministry of SMEs and Startups (MSS)  

07｜Certified R&D Department - Ministry of Science and ICT    

mobile background
2018

01｜Establishment of MediImg

mobile background
MediImg collaborates with a diverse range of partners. 

MediImg Co., Ltd. | Est. 2018

Business License No. : 313-87-00931

Head Office: #508, SBA Hub, Mapo-gu, Seoul, Korea

R&D Center: #6, 2F, Seoul National University Hospital Healthcare Innovation Park, Bundang, Gyeonggi-do, Korea

TEL : (+82) 02-484-5773 | FAX : (+82) 02-6499-6448

E-mail : info@mediimg.com

FDA 510K Approval Date : October 15, 2024

Copyright © 2025 MEDIIMG Co., Ltd. All rights reserved.


Approved by the MFDS

MediImg Co., Ltd. | Est. 2018 

Business License No. : 313-87-00931 

Head Office: #508, SBA Hub, Mapo-gu, Seoul, Korea

R&D Center: #6, 2F, Seoul National University Hospital Healthcare Innovation Park,

Bundang, Gyeonggi-do, Korea

TEL : (+82) 02-484-5773 | FAX : (+82) 02-6499-6448 | E-mail｜info@mediimg.com

FDA 510K Approval Date : October 15, 2024

Approved by the MFDS

Copyright © 2025 MEDIIMG Co., Ltd. All rights reserved.

Contact 네이버 블로그 유튜브 인스타그램